BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mugisho OO, Rupenthal ID, Paquet-Durand F, Acosta ML, Green CR. Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye disease. Expert Opin Ther Targets 2019;23:855-63. [PMID: 31554417 DOI: 10.1080/14728222.2019.1673368] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Coutinho FP, Green CR, Acosta ML, Rupenthal ID. Xentry-Gap19 inhibits Connexin43 hemichannel opening especially during hypoxic injury. Drug Deliv Transl Res 2020;10:751-65. [PMID: 32318976 DOI: 10.1007/s13346-020-00763-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
2 Shome A, Mugisho OO, Niederer RL, Rupenthal ID. Blocking the inflammasome: A novel approach to treat uveitis. Drug Discov Today 2021:S1359-6446(21)00306-8. [PMID: 34229084 DOI: 10.1016/j.drudis.2021.06.017] [Reference Citation Analysis]
3 Mugisho OO, Green CR. The NLRP3 inflammasome in age-related eye disease: Evidence-based connexin hemichannel therapeutics. Exp Eye Res 2021;215:108911. [PMID: 34958779 DOI: 10.1016/j.exer.2021.108911] [Reference Citation Analysis]
4 Cooreman A, Caufriez A, Tabernilla A, Van Campenhout R, Leroy K, Kadam P, Sanz Serrano J, dos Santos Rodrigues B, Annaert P, Vinken M. Effects of Drugs Formerly Proposed for COVID-19 Treatment on Connexin43 Hemichannels. IJMS 2022;23:5018. [DOI: 10.3390/ijms23095018] [Reference Citation Analysis]
5 Garcia-Vega L, O'Shaughnessy EM, Albuloushi A, Martin PE. Connexins and the Epithelial Tissue Barrier: A Focus on Connexin 26. Biology (Basel) 2021;10:59. [PMID: 33466954 DOI: 10.3390/biology10010059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Zhang J, Green CR, Mugisho OO. Cell transdifferentiation in ocular disease: Potential role for connexin channels. Exp Cell Res 2021;407:112823. [PMID: 34506760 DOI: 10.1016/j.yexcr.2021.112823] [Reference Citation Analysis]
7 Marsh SR, Williams ZJ, Pridham KJ, Gourdie RG. Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine. J Cardiovasc Dev Dis 2021;8:52. [PMID: 34063001 DOI: 10.3390/jcdd8050052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Andelova K, Egan Benova T, Szeiffova Bacova B, Sykora M, Prado NJ, Diez ER, Hlivak P, Tribulova N. Cardiac Connexin-43 Hemichannels and Pannexin1 Channels: Provocative Antiarrhythmic Targets. Int J Mol Sci 2020;22:E260. [PMID: 33383853 DOI: 10.3390/ijms22010260] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Potter JA, Price GW, Cliff CL, Green CR, Squires PE, Hills CE. Collagen I Modifies Connexin-43 Hemichannel Activity via Integrin α2β1 Binding in TGFβ1-Evoked Renal Tubular Epithelial Cells. Int J Mol Sci 2021;22:3644. [PMID: 33807408 DOI: 10.3390/ijms22073644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Acosta ML, Mat Nor MN, Guo CX, Mugisho OO, Coutinho FP, Rupenthal ID, Green CR. Connexin therapeutics: blocking connexin hemichannel pores is distinct from blocking pannexin channels or gap junctions. Neural Regen Res 2021;16:482-8. [PMID: 32985469 DOI: 10.4103/1673-5374.290097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
11 Mat Nor MN, Rupenthal ID, Green CR, Acosta ML. Differential Action of Connexin Hemichannel and Pannexin Channel Therapeutics for Potential Treatment of Retinal Diseases. Int J Mol Sci 2021;22:1755. [PMID: 33578721 DOI: 10.3390/ijms22041755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Louie HH, Shome A, Kuo CY, Rupenthal ID, Green CR, Mugisho OO. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy. Exp Eye Res 2021;202:108384. [PMID: 33285185 DOI: 10.1016/j.exer.2020.108384] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Yang TT, Qian F, Liu L, Peng XC, Huang JR, Ren BX, Tang FR. Astroglial connexins in epileptogenesis. Seizure 2021;84:122-8. [PMID: 33348235 DOI: 10.1016/j.seizure.2020.11.022] [Reference Citation Analysis]